Clinofibrate - Targetmol

Home > Metabolism > HMG/CoA Reductase > Clinofibrate

Clinofibrate

Catalog No. T6450 CAS 30299-08-2

Pack Size	Availability	Price/USD
25mg	In stock	189.00
50mg	In stock	266.00
100mg	In stock	479.00
200mg	In stock	862.00
1 mL * 10 mM (in DMSO)	In stock	53.00
Bulk Size: Please Quote for Discount

Documents and Quality Management

Purity：99.84%

COA

Datasheet

HNMR

HPLC

MSDS

Biological Activity:

Product Description:

Clinofibrate（IC50 of 0.47 mM）, a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood.

Target:
HMGCR;

Research Area:
Metabolism system

Chemical Information:

Molecular Weight	468.58
Formula	C₂₈H₃₆O₆
CAS Number	30299-08-2
Solubility	DMSO:87 mg/mL (185.7 mM);Ethanol:87 mg/mL (185.7 mM)
Storage	3 years -20°C powder; 2 years -80°C in solvent;
Remark	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.

Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries

This product is contained In the following compound libraries：

Product Recommendations

Atorvastatin Calcium, Atorvastatin hemicalcium salt， an effective HMG-CoA reductase inhibitor (IC50 = 8 nM)， is utilized a...
Rosuvastatin, Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (...
Meglutol, Meglutol is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins an...
Rosuvastatin calcium, Rosuvastatin, a selective and competitive inhibitor of hepatic hydroxymethyl-glutaryl coenzyme A (HM...
Fluvastatin sodium salt, Fluvastatin sodium, a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), i...

Reference

1. Matsuura K, et al, J Pharmacol Exp Ther, 1998, 285(3), 1096-1103.

If you have additional questions, Please send us a message. * Required